Schedule 13D ownership disclosure
Aegerion Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00767E102
Event date: 2016-06-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-16-013770
- Form type
- SC 13D
- Filer
- Aegerion Pharmaceuticals, Inc.
- CIK
- CIK 1338042
- Filed
- Jun 22, 2016
- Reporting period
- Jun 14, 2016
- Description
- Schedule 13D beneficial ownership